Search for Clinical Trial Results

Sponsored By

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - 8 Studies Found

Status Study
Active, not recruiting Study Name: Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Condition:
  • Leukemia, Lymphoid
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Date: 2010-04-26
    Interventions: Drug: Lenalidomide plus dexamethasone Lenalidomide 25 mg p.o. once daily on days 1-21 plus Dexamethasone
Terminated Study Name: Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Condition:
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Acute Lymphobl
    Date: 2009-05-15
    Interventions: Drug: Nilotinib 400mg, Oral, Bid, Daily for three years
Active, not recruiting Study Name: A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Condition:
  • Burkitt Lymphoma
  • Precursor B-cell Lymphoblastic Leukemia-Lymphoma Date: 2013-02-05
    Interventions: Drug: SGN-CD19A SGN-CD19A (IV) once (Day 1) or twice (Days 1 and 8) every 21 days; dose range: 0.3-6 mg/
Terminated Study Name: A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
Condition:
  • Acute Lymphoblastic Leukemia
  • Precursor B-Cell Lymphoblastic Leukemia Date: 2011-11-29
    Interventions:
    • Drug: Decitabine 10 mg/m2/day

Completed Study Name: Coproporphyrine Isomers and Methotrexate Elimination
Condition:
  • Central Nervous System Neoplasms
  • Lymphoma, Large B-Cell, Diffuse
  • Burkitt Lymphoma
  • Lymphoma, Follicular
  • Lymphoma, Large B-Ce
    Date: 2013-02-05
    Interventions: Drug: SGN-CD19A SGN-CD19A (IV) once every 21 days (3 weeks) or 42 days (6 weeks)
Completed Study Name: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)
Condition:
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Leukemia, Myel
    Date: 2009-03-17
    Interventions:
    • Biological: Hematopoietic Umbilical Cord Blood Stem Cell Transplantation

Completed Study Name: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
Condition:
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Leukemia, Myel
    Date: 2009-02-20
    Interventions:
    • Biological: Haploidentical Bone Marrow Transplantation